Others have reported that gigantol inhibits the proliferation of breast cancer cells by downregulation of the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway [26]. Here, AKT1 is linked to breast carcinoma.